US FDA approves use of Pfizer COVID-19 vaccine for 12-15 age group

DY365
DY365
Published: May 11,2021 11:27 AM
DY365

Story highlights

The US Food and Drug Administration (FDA) expanded the emergency use authorization of Pfizer/BioNTech’s COVID-19 vaccine for children ages 12 to 15 years.

May 11, 2021: The US Food and Drug Administration (FDA) expanded the emergency use authorization of Pfizer/BioNTech’s COVID-19 vaccine for children ages 12 to 15 years.



With this, Pfizer became the first vaccine in the United States to be authorized for use in younger teens and adolescents; the vaccine had previously been authorized for people age 16 and older.



The FDA Executive Commissioner Dr. Janet Woodcock said, “The expansion brings us closer to returning to a sense of normalcy. Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations.



At the same time, Pfizer-BioNTech’s COVID-19 vaccine currently used by adults in many countries. Pfizer released the data in March and said that 2,260 volunteers of 12-15 years given the vaccine. Meanwhile, the clinical trials found “100% efficacy and robust antibody responses” in study participants who were 12 to 15.”